Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO4607381 in coronary heart disease or equivalent cardiovascular risk
2007-003406-10Phase 2Completed
- Sponsor
- Roche
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronary arteriosclerosis and lipid metabolism disorder comparing RO4607381 with Placebo (2 arms). Primary endpoint: Change from baseline in flow-mediated dilatation. Started Oct 2007; status: completed.
02
Drugs
dalcetrapib
03
Conditions
coronary arteriosclerosislipid metabolism disorder
Beyond the preview
Go deeper on 2007-003406-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003406-10.